Evidence map›Paper›PMID 35326940›Full record

ArticleHealthcare (Basel, Switzerland)2022

Epidemiological Algorithm for Early Detection of COVID-19 Cases in a Mexican Oncologic Center.

Moisés González-Escamilla, Diana Cristina Pérez-Ibave, Carlos Horacio Burciaga-Flores, Vanessa Natali Ortiz-Murillo, Genaro A Ramírez-Correa, Patricia Rodríguez-Niño, Rafael Piñeiro-Retif, Hazyadee Frecia Rodríguez-Gutiérrez, Fernando Alcorta-Nuñez, Juan Francisco González-Guerrero and 2 more

Open access · goldAbstract read
In one paragraph

Article in Healthcare (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 2 countries.

Moisés González-EscamillaCentro Universitario Contra el Cáncer, Universidad Autónoma de Nuevo León, Hospital Universitario "Dr. José Eleuterio González", Av. Francisco I. Madero S/N, Mitras Centro, Monterrey 64460, Mexico.
Diana Cristina Pérez-IbaveCentro Universitario Contra el Cáncer, Universidad Autónoma de Nuevo León, Hospital Universitario "Dr. José Eleuterio González", Av. Francisco I. Madero S/N, Mitras Centro, Monterrey 64460, Mexico.
Carlos Horacio Burciaga-FloresCentro Universitario Contra el Cáncer, Universidad Autónoma de Nuevo León, Hospital Universitario "Dr. José Eleuterio González", Av. Francisco I. Madero S/N, Mitras Centro, Monterrey 64460, Mexico.
Vanessa Natali Ortiz-MurilloFacultad de Medicina, Universidad Autónoma de Nuevo León, Av. Francisco I. Madero S/N, Mitras Centro Monterrey, Monterrey 64460, Mexico.
Genaro A Ramírez-CorreaDepartment of Molecular Science, The University of Texas Rio Grande Valley School of Medicine, McAllen, TX 78504, USA.
Patricia Rodríguez-NiñoCentro Universitario Contra el Cáncer, Universidad Autónoma de Nuevo León, Hospital Universitario "Dr. José Eleuterio González", Av. Francisco I. Madero S/N, Mitras Centro, Monterrey 64460, Mexico.
Rafael Piñeiro-RetifCentro Universitario Contra el Cáncer, Universidad Autónoma de Nuevo León, Hospital Universitario "Dr. José Eleuterio González", Av. Francisco I. Madero S/N, Mitras Centro, Monterrey 64460, Mexico.
Hazyadee Frecia Rodríguez-GutiérrezCentro Universitario Contra el Cáncer, Universidad Autónoma de Nuevo León, Hospital Universitario "Dr. José Eleuterio González", Av. Francisco I. Madero S/N, Mitras Centro, Monterrey 64460, Mexico.ORCID 0000-0001-5764-4243
Fernando Alcorta-NuñezCentro Universitario Contra el Cáncer, Universidad Autónoma de Nuevo León, Hospital Universitario "Dr. José Eleuterio González", Av. Francisco I. Madero S/N, Mitras Centro, Monterrey 64460, Mexico.
Juan Francisco González-GuerreroCentro Universitario Contra el Cáncer, Universidad Autónoma de Nuevo León, Hospital Universitario "Dr. José Eleuterio González", Av. Francisco I. Madero S/N, Mitras Centro, Monterrey 64460, Mexico.
Oscar Vidal-GutiérrezCentro Universitario Contra el Cáncer, Universidad Autónoma de Nuevo León, Hospital Universitario "Dr. José Eleuterio González", Av. Francisco I. Madero S/N, Mitras Centro, Monterrey 64460, Mexico.
María Lourdes Garza-RodríguezCentro Universitario Contra el Cáncer, Universidad Autónoma de Nuevo León, Hospital Universitario "Dr. José Eleuterio González", Av. Francisco I. Madero S/N, Mitras Centro, Monterrey 64460, Mexico.ORCID 0000-0001-7096-2713
Universidad Autónoma de Nuevo León · MXJohns Hopkins University · US

Funding

Novel quantitative proteomic approaches to define the altered interplay between OGlcNAcylation and Phosphorylation in myofilament dysfunction of diabetic heartsK01HL133368 · NHLBI · UNIVERSITY OF TEXAS RIO GRANDE VALLEY · PI RAMIREZ-CORREA, GENARO ANTONIO · 2016 to 2020
$623k
NHLBI NIH HHS K01 HL133368
6 · The paper itself

Abstract

An early detection tool for latent COVID-19 infections in oncology staff and patients is essential to prevent outbreaks in a cancer center. (1) Background: In this study, we developed and implemented two early detection tools for the radiotherapy area to identify COVID-19 cases opportunely. (2) Methods: Staff and patients answered a questionnaire (electronic and paper surveys, respectively) with clinical and epidemiological information. The data were collected through two online survey tools: Real-Time Tracking (R-Track) and Summary of Factors (S-Facts). Cut-off values were established according to the algorithm models. SARS-CoV-2 qRT-PCR tests confirmed the positive algorithms individuals. (3) Results: Oncology staff members (

Indexed as

COVID-19electronic early detection toolspreventionSARS-CoV-2

Identifiers

PMID35326940
PMCPMC8950794
OpenAlexW4214497950

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.